Evidence map›Paper›PMID 27144624›Full record

ArticleGastroenterology2016

Biopsychosocial Aspects of Functional Gastrointestinal Disorders.

Lukas Van Oudenhove, Michael D Crowell, Douglas A Drossman, Albena D Halpert, Laurie Keefer, Jeffrey M Lackner, Tasha B Murphy, Bruce D Naliboff, Rona L Levy

2 registry-linked trialsAbstract read
In one paragraph

Article in Gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 231 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
231citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06268964 phase1 / phase2recruitingnot on this mapstarted 2024, after this paper: background citation

Comparative Effect of Trimebutine and Probiotics on Functional Abdominal Pain Disorders (FAPD) in Children: Randomized Clinical Trial (RCT)

TypeinterventionalSponsorUniversidad de ColimaRan2024 to 2025Enrolled82ConditionsFunctional Abdominal Pain Syndrome, Functional Gastrointestinal Disorders, Irritable Bowel Syndrome Variant of ChildhoodArmsTrimebutine, Lactobacillus rhamnosus, Placebo
NCT07636122 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Internet-delivered Psychological Treatment of Functional Gastrointestinal Disorders - A Danish Feasibility Study

TypeinterventionalSponsorUniversity of AarhusRan2026 to 2027Enrolled30ConditionsFunctional Gastrointestinal Disorders (FGID)ArmsI-CBT
3 · Its place in the literature

Who cites it

231 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Guideline
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel Syndrome.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2019
    Trial
  16. Trial
  17. A Postbiotic ContainingMicroorganisms · 2026
    Article
  18. Article
  19. Article
  20. Article

171 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lukas Van OudenhoveLaboratory for Brain-Gut Axis Studies (LABGAS), Translational Research Center for Gastrointestinal Disorders (TARGID), University of Leuven, Belgium.
Michael D CrowellDepartment of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, USA.
Douglas A DrossmanProfessor Emeritus of Medicine and Psychiatry, University of North Carolina, Center for Education and Practice of Biopsychosocial Care LLC, Drossman Gastroenterology PLLC, Chapel Hill, NC, USA.
Albena D HalpertCenter for Digestive Disorders, Boston Medical Center, USA, Pentucket Medical Associates, Haverhill, MA, USA.
Laurie KeeferDivision of Gastroenterology, Ichan School of Medicine at Mount Sinai, New York, NY, USA.
Jeffrey M LacknerBehavioral Medicine Clinic, Department of Medicine, University at Buffalo School of Medicine and Biomedical Sciences, State University of New York, NY, USA.
Tasha B MurphyBehavioral Medicine Research Group, School of Social Work, University of Washington, Seattle, WA, USA.
Bruce D NaliboffCenter for Neurobiology of Stress, Departments of Medicine and Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Rona L LevyBehavioral Medicine Research Group, School of Social Work, University of Washington, Seattle, WA, USA.

Funding

Self-Administered CBT for IBS: A Multicenter TrialU01DK077738 · NIDDK · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI LACKNER, JEFFREY M · 2008 to 2014
$8.1M
NIDDK NIH HHS U01 DK077738
6 · The paper itself

Abstract

In this paper, we provide a general framework for understanding the functional gastrointestinal disorders (FGID) from a biopsychosocial perspective. More specifically, we provide an overview of the recent research on how the complex interactions of environmental, psychological, and biological factors contribute to the development and maintenance of the FGID. We emphasize that considering and addressing all these factors is a conditio sine qua non for appropriate treatment of these conditions. First, we provide an overview of what is currently known about how each of these factors - the environment, including the influence of those in an individual's family, the individual's own psychological states and traits, and the individual's (neuro)physiological make-up - interact to ultimately result in the generation of FGID symptoms. Second, we provide an overview of commonly used assessment tools which can assist clinicians in obtaining a more comprehensive assessment of these factors in their patients. Finally, the broader perspective outlined earlier is applied to provide an overview of centrally acting treatment strategies, both psychological and pharmacological, which have been shown to be efficacious to treat FGID.

Indexed as

Adverse life eventsanxietycognitive behavioral therapydepressionexposure treatmentshypnosissomatic symptom disorder

Identifiers

PMID27144624
PMCPMC8809487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.